Hyderabad, October 14th, 2025 : More than 30 million couples in India are facing infertility
issues, underscoring the urgent need for deeper, India-specific fertility
research and evidence-based clinical practices. Recognizing this national
challenge, Ferty9 Fertility Centre has announced the appointment of Prof. Roy
Homburg, world-renowned reproductive medicine expert, as its Clinical Research
Advisor.
This strategic move marks a significant milestone in
Ferty9’s mission to bridge global scientific expertise with India’s unique
reproductive health landscape. Prof. Homburg’s appointment comes soon after the
successful conclusion of Fertygyaan 2025, Ferty9’s international conference
that convened hundreds of leading gynaecologists, embryologists, and fertility
specialists from across the world to discuss evolving clinical trends,
technologies, and policy frameworks in reproductive healthcare.
India faces a critical need for robust, evidence-based
fertility research, as its vast ethnic and genetic diversity presents unique
reproductive challenges. Significant gaps persist due to limited infrastructure
and funding. Under Prof. Homburg’s mentorship, Ferty9 will develop large-scale,
India-specific IVF studies, strengthen clinical and embryology capabilities,
and generate insights to inform best practices nationwide. By building a
culture of rigorous research, Ferty9 aims to enhance patient outcomes across
India while contributing knowledge that advances fertility care globally.
Speaking to the media, Dr. Roy Homburg said “I am
truly inspired by the enthusiasm and scientific curiosity demonstrated by
Ferty9 in advancing fertility research. The quality of discussions and
presentations at Fertygyaan 2025 was tremendous, and the participation of over
a thousand professionals highlights India’s growing commitment to understanding
and addressing infertility. With more than 30 million couples affected, there
lies a tremendous opportunity to deepen our understanding and develop more
effective treatments that bring hope to millions. Research in fertility is both
intellectually stimulating and personally rewarding, as it directly improves
lives and families.”
“India has the infrastructure, expertise, and
determination to conduct world-class fertility research, and Ferty9’s advanced
facilities reflect that capability beautifully. I am delighted to collaborate
with Ferty9 in driving innovation and improving reproductive healthcare
outcomes. I love India, its energy, talent, and compassion make it a remarkable
place to conduct meaningful scientific work and contribute to a brighter, more
fertile future,” added Dr. Roy Homburg.
Emphasizing the urgency of localized research, Dr.
Jyothi, Medical Director, Ferty9 Fertility Centre said, “India stands at a
crucial point where addressing fertility challenges is not just a medical
priority but a national need. If we do not act now, our youth population will
inevitably decline, affecting the demographic strength that defines our nation.
Delaying parenthood, genetic factors, and conditions such as PCOS are among the
leading causes of infertility today. Yet, India has not conducted enough
large-scale, indigenous studies to understand these patterns. Research shows
that ovarian ageing among Indian women occurs 6.3 years earlier than in
Caucasian women, which calls for urgent India-specific data and treatment
protocols. With the mentorship of Prof. Roy Homburg, whose research and
publications are foundational for gynaecologists worldwide, Ferty9 aims to
champion a new era of evidence-based fertility care. Our mission is to
understand the Indian woman’s body better, personalize treatments, and help
every couple experience the joy of parenthood.”
Adding further, Mr. Vinesh Gadhia, Executive Director
& CEO, Ferty9 said, “India’s fertility landscape presents unique
challenges due to its ethnic diversity, genetic variations, and changing
lifestyle patterns. Despite a rapidly growing demand for fertility services,
indigenous research remains limited with most treatment protocols still modeled
on Western populations.
Ferty9 aims to address this gap by conducting
large-scale, India-focused reproductive studies under Prof. Homburg’s
mentorship, strengthening clinical capabilities, and building a research-driven
ecosystem.”
“With decades of innovation in laboratory science and
clinical practice, where embryos are created, nurtured, and prepared for
transfer, couples today can stay assured of better IVF success. Behind every
successful cycle lies a meticulously designed lab environment that protects
embryos in their most delicate stages of development,” said Mr. Javier Herrero
Zapata, Embryology Consultant and Advisor, Ferty9. “Ferty9’s experience and
precision-driven approach continue to deliver consistently high success rates
and renewed hope for countless couples.
